Pipeline
At Cephalon, we’re developing therapeutics agents in the areas of central nervous system disorders, inflammatory diseases, oncology, and pain.
Our clinical development program includes small molecules, peptides, and biologics in various stages of discovery and development. And, we are working on expanding the indications for some of our existing medicines in an effort to bring these therapies to a greater number of patients in need.
Learn more about our portfolio of innovative products.
